Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

NCT: NCT07175129 · WITHDRAWN

NCT IDNCT07175129
StatusWITHDRAWN
Start Date2026-01-05
Completion2027-06

Brief Summary

Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease that doctors are unable to restore blood flow using standard treatments like surgery or stents. For these patients, major amputation may be the only remaining option. This study aims to test a new surgical technique called transverse tibial bone transport, which has been shown in some previous small studies to help improve blood flow and promote healing of wounds in the legs and feet. These early studies suggest that the procedure may help wounds heal better and reduce the need for amputation in people with severe circulation problems. This research will help us learn more about how safe and effective this technique is for patients who have no other treatment options other than amputation.

Frequently Asked Questions

What is Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)?

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI) is a clinical trial registered under NCT07175129. Current status: WITHDRAWN.

What is the status of NCT07175129?

The current status of NCT07175129 (Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)) is: WITHDRAWN.

When did Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI) start?

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI) started on 2026-01-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.